Bardia Moayedi, Partner at our San Diego, and Orange County law offices
vCard

Bardia Moayedi

Partner
Biography

Bardia Moayedi is a corporate and securities partner, chair of the firm’s Technology Industry Group and co-chair of the firm’s Life Sciences Industry Group. He primarily advises emerging growth and public companies throughout their life cycles as well as venture capital and private equity firms, particularly in the life sciences, high-technology, financial technology, food and beverage, and clean-technology industries.

Bardia has significant experience representing companies and financial firms in a broad range of general corporate governance and transactional matters, including venture capital financings, mergers and acquisitions, debt offerings, spin-offs/divestitures, joint ventures, IPOs, follow-on offerings, and tender offers. He is a trusted advisor, often serving as the go-to outside counsel or lead counsel to his clients.

Prior to attending law school, Bardia worked at a prominent investment bank, where he focused on hedge funds and private equity funds. As an undergraduate, he played ice and roller hockey at UCLA.

Credentials

Bar Admissions

  • California


Education

  • University of San Diego School of Law, (J.D.)
  • University of California, Los Angeles, (B.A.)

Languages

Persian

Experience

Awards & Recognition

Representative Experience

Startups and Venture Capital

  • Extensive experience representing companies and venture capital firms in numerous convertible note, SAFE and seed financings
  • Extensive experience representing companies and venture capital firms in numerous Series A through pre-IPO preferred stock financings

Mergers and Acquisitions

  • Represented a therapeutics company in its over $600 million acquisition by a Fortune 100 company
  • Represented a medical device company in its $400 million acquisition by a Fortune 100 company
  • Represented a biotherapeutics company in its $300 million acquisition by a Fortune 100 company
  • Represented a high-technology company in its over $250 million acquisition by a Fortune 100 company
  • Represented a pharmaceutical company in its over $200 million acquisition by a publicly traded company
  • Represented a high-technology company in its $200 million acquisition by a publicly traded company

Capital Markets

  • Represented a clinical-stage immunotherapy company in its over $200 million IPO
  • Represented a high-technology company in its over $100 million IPO
  • Represented a medical device company in its over $70 million IPO
  • Represented a biotherapeutics company in its over $50 million IPO
  • Represented a clinical-stage biosimilars company in its $50 million IPO
  • Represented a publicly traded company in its over $200 million tender offer
  • Represented a publicly traded company in its $200 million tender offer

Previous Professional Experience

  • Troutman Pepper, Corporate Attorney
  • Mintz Levin, Corporate Attorney
  • Wilson Sonsini Goodrich & Rosati, Corporate Attorney
  • U.S. Securities and Exchange Commission, Summer Honors Program
  • Merrill Lynch, Investment Associate

Professional Memberships and Activities

  • UC San Diego Affiliate Professor – Business Development, Entrepreneurship, Corporate, and Intellectual Property Strategy
  • UC Irvine Applied Innovation Incubator, Advisor
  • SDSU ZIP Launchpad, Advisor
  • UC Hastings Start-up Legal Garage, Advisor
  • San Diego Venture Group, Member
  • Iranian American Bar Association, Member
  • Biocom California, Member

Representative Presentations and Publications

  • “Seed & Series A Rounds in 2024 – Investor Startup Expectations: A Moving Target” Moderator, Venture San Diego (May 1, 2024)
  • Why Sequoia’s Klarna board drama made the VC world wince” Quoted, PitchBook (February 23, 2024)
  • “Formation and Seed Funding for Startups”, Presenter, Venture San Diego (January 17, 2024)
  • “Building Life Science Startups” Panelist, Orange County Lifesciences Innovators Forum (June 28, 2023)
  • Managing Money: How Treasury Management Impacts Your Business”, Co-Presenter, AZBioPEERS (April 19, 2023)
  • Biotech Deals Provide a Split-Screen Moment for Battered Sector” Quoted, Axios (March 14, 2023)
  • Nonbank Lenders Pounce on Venture Debt Market After SVB Collapse” Quoted, PitchBook (March 14, 2023)
  • Health Tech Funding Crunch Tightens” Quoted, AxiosPro (March 13, 2023)
  • Corporate Attorney Working in Sustainability” Quoted, Green.org (November 23, 2022)
  • “Venture Capital Financing 101” Speaker, SBDC @ University of California, Irvine Beall Applied Innovation Incubator (July 19, 2022)
  • “Frazier Healthcare Partners Raises $986 Million Biotech Venture Fund” Quoted, Wall Street Journal WSJ Pro: Venture Capital (March 16, 2022)
  • “Investors Optimistic About 2022, But Not All Signs Point Up” Quoted, Wall Street Journal Pro (December 23, 2021)
  • “Pitch. Launch. Grow. Demo Day.” Judge Panelist, SBDC @ University of California, Irvine Beall Applied Innovation Incubator (August 26, 2021)
  • Board of Directors – When You May Need Board Approval and Why,“ Episode Host, CalCurrent Podcast (May 20, 2021)
  • “Negotiating/Understanding Your Initial Angel and Venture Funding Round (SAFEs, Convertible Notes, Seed and Series A),” Speaker, SBDC @ University of California, Irvine Beall Applied Innovation Incubator (May 10, 2021)
  • “IP for Startups – IP and Venture Fundraising,” Panelist, SBDC @ University of California, Irvine Beall Applied Innovation Incubator (January 27, 2021)
  • “Financial Recovery,” Panelist, SBDC @ University of California, Irvine Beall Applied Innovation Incubator, (August 18, 2020)
  • “Late-Stage Startup Financing,” Speaker, Talk Tech Webinars (February 5, 2020)
  • “Venture Financing Options, Structures and Risks,” Speaker, Talk Tech Webinars (October 23, 2019)
  • “Venture Financings 101 (SAFEs, Convertible Notes, Seed and Series A),” Speaker, University of California, Irvine Applied Innovation (July 12, 2019)
  • “Corporate Transactions and the Law,” Panelist, UC San Diego Rady School of Management (2018)
  • “Founder’s Bootcamp,” Panelist, San Diego State University ZIP Launchpad (2018)
  • “Negotiating Your Series A,” Speaker, Los Angeles Clean Tech Incubator (2017)
  • “Convertible Note and Series A Financings,” Guest Lecturer, Tech/Entrepreneurship Clinic, University of San Diego School of Law (2017)
  • “Startup 101,” Speaker, Los Angeles Clean Tech Incubator (2017)
  • “Startup Nuts & Bolts,” Speaker, San Diego State University ZIP Launchpad (2017)
  • “IPOs,” Guest Lecturer, University of San Diego School of Law – Advanced Corporate Transactional Skills (2016)
Client News
Client News
Jul 24, 2024

Snell & Wilmer Advises Drug Development Company Brenig Therapeutics, Inc. as it Secures $65 Million in Series A Financing

Client News
Jul 09, 2024

Snell & Wilmer Represents Vizzia Technologies in Sale to HID

Client News
Apr 02, 2024

Snell & Wilmer Advises Biotechnology Company Trawsfynydd Therapeutics, Inc. in Merger with Onconova Therapeutics, Inc.

Client News
Mar 28, 2024

Snell & Wilmer Advises Technology-Focused Growth Equity Firm Blueprint Equity as it Leads $8 Million Series A Funding of Sprocket Security